Otophylloside T is primarily investigated for its potential anti-inflammatory and neuroprotective properties. It has shown activity in modulating pathways associated with oxidative stress in neuronal cells, making it a compound of interest in research on neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. Studies suggest it may help reduce the production of pro-inflammatory cytokines and inhibit reactive oxygen species (ROS) accumulation in brain tissue. Additionally, it has been explored for its ototoxic protective effects, particularly in models of hearing loss linked to inner ear damage, due to its ability to support cell viability in auditory pathways. Its natural origin and bioactivity profile make it a candidate for development in therapeutic agents targeting neurological and sensory disorders, though it remains mainly in the preclinical research phase.